Lamotrigine Tablet
Product Images NDC 68071-3944

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 68071-3944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3944 6)

Pdp (68071 3944 6)
This text provides detailed information about a medication called Lamotrigine 100mg. The text includes details such as the manufacturer's information, expiration date, lot number, and dosage form. Additionally, it also emphasizes the importance of keeping the medication out of reach of children and storing it at a controlled temperature range of 68-77°F.*
FDA Label Image

Tabs (Lamo Tabs Med Guid Pg2)

Tabs (Lamo Tabs Med Guid Pg2)
This text provides important information about the medication Lamotrigine tablets. It explains the risks of stopping the medication suddenly, including the possibility of serious problems such as suicidal thoughts and aseptic meningitis. The text also lists symptoms to watch for and emphasizes the importance of taking the correct medication dosage. It includes descriptions and images of different strengths of Lamotrigine tablets to help patients ensure they are receiving the right medication. Overall, this text serves as a comprehensive guide for patients prescribed Lamotrigine tablets.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg1)

Tabs (Lamo Tabs Med Guide Pg1)
This is a medication guide for Lamotrigine tablets, which are used to treat various conditions such as epilepsy and bipolar disorder. The text emphasizes important information such as the risk of serious skin rash, allergic reactions, liver problems, and other potential side effects that may occur while taking this medication. It provides detailed guidance on when to seek medical help if certain symptoms like skin rash, fever, weakness, or unusual bruising occur. The text also highlights the possible risk of suicidal thoughts or actions that may be induced by the medication, urging individuals to seek help if experiencing such symptoms.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg 4)

Tabs (Lamo Tabs Med Guide Pg 4)
This text provides valuable information about the medication lamotrigine. It includes instructions on how to take the medication, possible side effects, storage guidelines, and what to avoid while taking lamotrigine tablets. It also mentions the importance of contacting a healthcare provider in case of side effects and the specifics about the ingredients in the tablets. Overall, this text serves as a medication guide approved by the U.S. Food and Drug Administration, offering essential details for those prescribed lamotrigine.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg.3.5)

Tabs (Lamo Tabs Med Guide Pg.3.5)
This is a set of guidelines for how to take lamotrigine tablets. It advises to take the medication exactly as prescribed by your healthcare provider, highlighting the importance of not changing the dose without consulting your provider. Stopping lamotrigine suddenly can lead to serious issues, especially for individuals with epilepsy, as it may cause seizures that do not stop. The text also mentions that if a dose is missed, it is recommended to take it as soon as you remember, or skip it if it is close to the next scheduled dose time, without taking two doses simultaneously.*
FDA Label Image

Tabs (Lamo Tabs Med Guide Pg3)

Tabs (Lamo Tabs Med Guide Pg3)
Lamotrigine is a prescription medication used to treat certain types of seizures in individuals aged 2 years and older. It can be used alone or in combination with other medicines for this purpose. Additionally, lamotrigine is prescribed for the long-term treatment of bipolar I disorder to extend the time between mood episodes in individuals who have received previous treatment with other medications. However, the safety and effectiveness of lamotrigine have not been established in individuals under 18 years of age with mood episodes such as bipolar disorder or depression. It is also not recommended for acute treatment of manic or mixed mood episodes. Prior to taking lamotrigine, it is essential to inform your healthcare provider about your medical history, including any allergies, genetic factors, mental health issues, and medication use. Additionally, certain precautions should be taken if you are pregnant, breastfeeding, or taking other medications to avoid potential interactions and side effects.*
FDA Label Image

Chemical Structure (Lamotrigine 01)

FDA Label Image

Figure 1 (Lamotrigine 02)

FDA Label Image

Figure 2 (Lamotrigine 03)

Figure 2 (Lamotrigine 03)
The text shows the Failure Probability (%) of placebo and lamotrigine. It can be used to compare the effectiveness of these two treatments in terms of reducing failure probability in a specific scenario.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.